Brokerages Set Cabot Corp (CBT) Target Price at $72.29

Cabot Corp (NYSE:CBT) has been given a consensus rating of “Buy” by the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $72.29.

CBT has been the subject of a number of analyst reports. Loop Capital raised shares of Cabot from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a report on Friday, January 5th. SunTrust Banks raised shares of Cabot to a “buy” rating and set a $73.00 price objective for the company in a report on Tuesday, January 16th. ValuEngine raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Zacks Investment Research downgraded shares of Cabot from a “buy” rating to a “hold” rating in a report on Thursday, January 18th. Finally, Robert W. Baird began coverage on shares of Cabot in a report on Tuesday, February 27th. They set a “neutral” rating and a $72.00 price objective for the company.

How to Become a New Pot Stock Millionaire

NYSE:CBT opened at $54.14 on Wednesday. The stock has a market cap of $3,445.13, a PE ratio of 15.84, a price-to-earnings-growth ratio of 1.37 and a beta of 1.40. Cabot has a 52 week low of $50.21 and a 52 week high of $68.63. The company has a quick ratio of 1.02, a current ratio of 1.63 and a debt-to-equity ratio of 0.43.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, February 6th. The specialty chemicals company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.15. The company had revenue of $720.00 million during the quarter, compared to the consensus estimate of $653.54 million. Cabot had a net margin of 2.30% and a return on equity of 15.01%. The firm’s revenue for the quarter was up 17.8% compared to the same quarter last year. During the same period last year, the firm earned $0.84 EPS. equities research analysts expect that Cabot will post 4.06 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, March 9th. Investors of record on Friday, February 23rd were given a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend was Thursday, February 22nd. Cabot’s dividend payout ratio (DPR) is currently 36.73%.

Several institutional investors have recently made changes to their positions in the stock. OppenheimerFunds Inc. increased its position in shares of Cabot by 6.5% during the 4th quarter. OppenheimerFunds Inc. now owns 13,782 shares of the specialty chemicals company’s stock worth $849,000 after purchasing an additional 844 shares in the last quarter. American International Group Inc. increased its position in shares of Cabot by 0.7% during the 4th quarter. American International Group Inc. now owns 128,162 shares of the specialty chemicals company’s stock worth $7,893,000 after purchasing an additional 855 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Cabot by 48.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,663 shares of the specialty chemicals company’s stock worth $226,000 after purchasing an additional 1,194 shares in the last quarter. Vident Investment Advisory LLC increased its position in shares of Cabot by 18.7% during the 4th quarter. Vident Investment Advisory LLC now owns 8,527 shares of the specialty chemicals company’s stock worth $525,000 after purchasing an additional 1,345 shares in the last quarter. Finally, Aperio Group LLC increased its position in shares of Cabot by 7.3% during the 4th quarter. Aperio Group LLC now owns 20,657 shares of the specialty chemicals company’s stock worth $1,272,000 after purchasing an additional 1,400 shares in the last quarter. Institutional investors and hedge funds own 87.18% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/brokerages-set-cabot-corp-cbt-target-price-at-72-29.html.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply